Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Respiratory Safety of Oliceridine in Propofol-Sedated Gastrointestinal Endoscopy
NCT07187765Completed
- Start
- Sep 2025
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of oliceridine (2 arms). Primary endpoint: Incidence of Hypoxemia (SpO2 <= 92%) During Sedation for Gastrointestinal Endoscopy. Started Sep 2025; status: completed.
02
Drugs
oliceridine
Beyond the preview
Go deeper on NCT07187765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07187765.